Health & Fitness
Health and Fitness
Health and Fitness
Sat, September 3, 2011
Fri, September 2, 2011
Thu, September 1, 2011
Wed, August 31, 2011 Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of... -- SAN DIEGO, Aug. 31, 2011 /PRNewswire/ --
Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:
Stifel Nicolaus 2011 Healthcare Conference | |||
Date: | Wednesday, September 7, 2011 | ||
Time: | 1:30pm Eastern Time (10:30am Pacific Time) | ||
Place: | Four Seasons Hotel in Boston | ||
Speaker: | Scott Byrd, SVP & Chief Commercial Officer | ||
UBS Global Life Sciences Conference | |||
Date: | Tuesday, September 20, 2011 | ||
Time: | 11:30am Eastern Time (8:30am Pacific Time) | ||
Place: | Grand Hyatt Hotel in New York City | ||
Speaker: | Ted Schroeder, President & CEO | ||
JMP Securities Healthcare Conference | |||
Date: | Wednesday, September 28, 2011 | ||
Time: | 9:30am Eastern Time (6:30am Pacific Time) | ||
Place: | The St. Regis Hotel in New York City | ||
Speaker: | Ted Schroeder, President & CEO | ||
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit [ www.cadencepharm.com ].
Contacts: | William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 | |
SOURCE Cadence Pharmaceuticals, Inc.
[ Back to top ] RELATED LINKS
[ http://www.cadencepharm.com ]
